Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial
This study sought to report the treatment effect of ticagrelor on myocardial infarction (MI) and the strategy for and impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. - Background - In PLATO, ticagrelor reduced cardiovascular death, MI, or stroke in patient...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
19 February 2014
|
| In: |
Journal of the American College of Cardiology
Year: 2014, Volume: 63, Issue: 15, Pages: 1493-1499 |
| ISSN: | 1558-3597 |
| DOI: | 10.1016/j.jacc.2014.01.038 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jacc.2014.01.038 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0735109714004562 |
| Author Notes: | Kenneth W. Mahaffey, Claes Held, Daniel M. Wojdyla, Stefan K. James, Hugo A. Katus, Steen Husted, Philippe Gabriel Steg, Christopher P. Cannon, Richard C. Becker, Robert F. Storey, Nardev S. Khurmi, José C. Nicolau, Cheuk-Man Yu, Diego Ardissino, Andrzej Budaj, Joao Morais, Debra Montgomery, Anders Himmelmann, Robert A. Harrington, Lars Wallentin |
| Summary: | This study sought to report the treatment effect of ticagrelor on myocardial infarction (MI) and the strategy for and impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. - Background - In PLATO, ticagrelor reduced cardiovascular death, MI, or stroke in patients with acute coronary syndromes (ACS). |
|---|---|
| Item Description: | Gesehen am 26.08.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1558-3597 |
| DOI: | 10.1016/j.jacc.2014.01.038 |